TD Cowen lowered the firm’s price target on Acadia Healthcare (ACHC) to $70 from $91 and keeps a Buy rating on the shares. The firm noted the company issued revised 2024 guidance given disruptions in referral volumes related to recent newsflow and legal inquiries.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACHC:
- Acadia Healthcare price target lowered to $45 from $75 at Deutsche Bank
- Acadia Healthcare Reports Strong Q3 2024 Results
- Closing Bell Movers: Microsoft, Meta both down about 3% despite earnings beats
- Acadia Healthcare cuts FY24 EPS view to $3.35-$3.45 from $3.45-$3.65
- Acadia Healthcare reports Q3 adjusted EPS 91c, consensus 90c